- Issuer ticker
-
ASND
- Reported as of
-
17 Nov 2026
- Net transaction value
-
-$5,277,720
- SEC form
-
4
- Accepted by SEC
-
18 Nov 2026, 16:36:03 UTC
Filing notes and source
Key filing fact
Anni Lotte Kirstine Sonderbjerg Pedersen filed Form 4 for Ascendis Pharma A/S (ASND) on 18 Nov 2026.
Key facts
- This page summarizes Anni Lotte Kirstine Sonderbjerg Pedersen's Form 4 filing for Ascendis Pharma A/S (ASND).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Nov 2026, 16:36.
Change
- Previous filing in this sequence was filed on 18 Mar 2026.
- Current net transaction value: -$5,277,720.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001965755
Primary reporting owner
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG
- Relationship
-
EVP & Chief Admin Officer
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ASND
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +20,000
- Change %
- +103%
- Price
-
$37.18*
- Shares after
- 39,460
- Date
- 17 Nov 2026
- Ownership
- Direct
ASND
transaction
Ordinary Shares
Sale
- Transaction value
- -$5,277,720
- Shares
- -20,000
- Change %
- -51%
- Price
-
$263.89
- Shares after
- 19,460
- Date
- 17 Nov 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ASND
transaction
Derivative
Warrants
Options Exercise
- Transaction value
- Shares
- -20,000
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 17 Nov 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 20,000
- Exercise price
- $37.18
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote